(Total Views: 102)
Posted On: 02/06/2017 1:42:52 PM
Post# of 23609
$ENTB Entest BioMedical Inc.'s Subsidiary Zander Therapeutics Makes Key Additions to Management Team as the Company Prepares to Move Forward in the $63 Billion Veterinary / Pet Market Niche
https://finance.yahoo.com/news/entest-biomedi...00598.html
https://finance.yahoo.com/news/entest-biomedi...00598.html
(0)
(0)Scroll down for more posts ▼
